PLIN5 anticorps (AA 300-400)

N° du produit ABIN363617

Détail du produit anti-PLIN5 anticorps

Antigène: PLIN5 (Perilipin 5 (PLIN5))

Épitope: AA 300-400

Reactivité: Humain, Souris, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLIN5 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Specificité: Reacts with OXPAT from human, mouse and bovine

Réactivité croisée (Details): Porcine (94 % ), Sheep (94 %).

Purification: Antigen affinity purified

Immunogène: Synthetic peptide made to a region of the human OXPAT protein within residues 300-400

Information d'application

Indications d'application:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC(1.0 - 5.0 μg/mL) WB(0.5 - 2.0 μg/mL)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.01 mg/mL

Buffer: PBS, glycerol 30 % , Sodium azide 0.1 %

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-20 °C

Stockage commentaire: Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Date de péremption: 6 months

Détails sur PLIN5

Antigène: PLIN5 (Perilipin 5 (PLIN5))

Autre désignation: OXPAT (PLIN5 Produits)

Synonymes: anticorps LSDA5, anticorps LSDP5, anticorps MLDP, anticorps OXPAT, anticorps 2310076L09Rik, anticorps AI415325, anticorps AW109675, anticorps Lsdp5, anticorps PAT-1, anticorps perilipin 5, anticorps PLIN5, anticorps Plin5

Sujet: OXPAT is a novel PAT-1 protein that is expressed in highly oxidative tissues.Lipid droplet proteins of the PAT family regulate cellular neutral lipid stores.OXPAT is induced by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator-activated receptor [PPAR] agonists), and genetic (muscle-specific PPAR alpha overexpression) disturbances that increase fatty acid utilization.It is suggested that OXPAT is a marker for PPAR activation and fatty acid oxidation.As well, it may contribute to adaptive responses to the fatty acid responsibility that accompanies fasting, insulin deficiency, and overnutrition, responses that are defective in obesity and type 2 diabetes.